The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Left ventricular hypertrophy in hypertension: its arrhythmogenic potential
Open accessAbstract
Left ventricular (LV) hypertrophy may reflect physiological adaptation to an increased work load of the heart following intense physical training. However, LV hypertrophy often represents a pathophysiologic condition, and can develop due to intrinsic stimuli (cardiomyopathy), or secondary to extrinsic stimuli, such as pressure or volume overload accompanying hypertension and valvar disease (fig 1). Myocardial hypertrophy is also part of the remodelling process following an acute myocardial infarction, and is a common finding in patients with congestive heart failure caused by systolic and/or diastolic LV dysfunction. Figure 1 Left ventricular hypertrophy, a condition with variable background. AMI, acute myocardial infarction; CMP, cardiomyopathy. The presence of LV hypertrophy is a strong independent risk factor for future cardiac events and all cause mortality.1 The risk for sudden cardiac death is increased in subjects with LV hypertrophy, independent of the aetiology, and this event occurs also in individuals with no or only mild prior symptoms related to cardiovascular disease. Intense animal and human research has identified some common features and provided a framework within which some crucial components can be explained. Thus, whether the focus is haemodynamic or electrophysiologic, there seems to be consensus as to the initiation of a fetal-like gene programme in myocardial hypertrophy.2,3 The insights into its consequences can be applied in the clinical management of individual patients. During recent years, experts with different backgrounds within cardiovascular medicine have aimed to create a united picture of cardiac hypertrophy and sudden cardiac death, and to present it in such a way that in can be integrated and applied into clinical cardiovascular practice. This article is an attempt to pursue this ambition. We focus on LV hypertrophy in human hypertension as a model of cardiac hypertrophy, and myocardial hypertrophy as a condition with “reduced repolarisation reserve”,w1 and thus a latent …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy
Schlaich, M. P., Kaye, D. M., Lambert, E., Sommerville, M., Socratous, F., & Esler, M. D. (2003) · Circulation · doi:10.1161/01.cir.0000081775.72651.b6 · Cited by 459
Cited by
Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction
Verma, A., Meris, A., Skali, H., Ghali, J. K., Arnold, J. M. O., Bourgoun, M., Velazquez, E. J., McMurray, J. J. V., Kober, L., Pfeffer, M. A., et al. (2008) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2008.05.012 · Cited by 288
Left Ventricular Hypertrophy and Clinical Outcomes in Hypertensive Patients
Ruilope, L. M., & Schmieder, R. E. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.16 · Cited by 258
Loche, E., Blackmore, H. L., Carpenter, A. A., Beeson, J. H., Pinnock, A., Ashmore, T. J., Aiken, C. E., de Almeida-Faria, J., Schoonejans, J. M., Giussani, D. A., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy082 · Cited by 105
Siervo, M., Lara, J., Jajja, A., Sutyarjoko, A., Ashor, A. W., Brandt, K., Qadir, O., Mathers, J. C., Benjamin, N., Winyard, P. G., et al. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.04.007 · Cited by 52
Metadata
- Authors
- Kahan, T., & Bergfeldt, L.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2005-01-18
- Volume
- 91
- Issue
- 2
- Pages
- 250-256
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2075085522
- Cited by
- 208
- References
- 1
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. https://app.cochat.ai/papers/10.1136/hrt.2004.042473
- The paper
- Kahan, T., & Bergfeldt, L. (2005). Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart. https://doi.org/10.1136/hrt.2004.042473
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.